€200Mln Pharma and CDMO investment (2015) by Sanofi for Insulin at Industriepark Höchst in Germany
About this project
Pharma and CDMO investment of € 200 mln by Sanofi at Industriepark Höchst in Germany, Europe, targeting the production of Insulin.
Investment details
| Park | |
|---|---|
| Amount | € 200 mln |
| Categories |
Pharma
Stats by PIPS →
CDMO
Stats by PIPS →
|
| Investors | 
Sanofi |
| Target substances |
Insulin
Product
|
Detailed data on 1200+ projects in Europe